Literature DB >> 22773770

Chronic intermittent hypoxia exposure improves left ventricular contractility in transgenic mice with heart failure.

Jahan Naghshin1, Rosa H Rodriguez, Eric M Davis, Lia C Romano, Kenneth R McGaffin, Christopher P O'Donnell.   

Abstract

We previously reported the unexpected finding that 4 wk of exposure to intermittent hypoxia (IH), which simulates the hypoxic stress of obstructive sleep apnea, improved LV cardiac function in healthy, lean C57BL/6J mice. The purpose of the present study was to assess the impact of 4 wk of IH on cardiac function in a transgenic murine model that exhibits a natural history of heart failure. We hypothesized that IH exposure would exacerbate cardiac decompensation in heart failure. Adult male FVB (wild type) and transgenic mice with cardiac overexpression of tumor necrosis factor α (TNF-αTG) at 10-12 wk of age were exposed to 4 wk of IH (nadir inspired oxygen 5-6% at 60 cycles/h for 12 h during light period) or intermittent air (IA) as control. Cardiac function was assessed by echocardiography and pressure-volume loop analyses, and mRNA and protein expression were performed on ventricular homogenates. TNF-αTG mice exposed to IA exhibited impaired LV contractility and increased LV dilation associated with markedly elevated cardiac expression of atrial natriuretic peptide and brain natriuretic peptide compared with wild-type mice. When wild-type FVB mice were exposed to IH, they exhibited increases in arterial pressure and dP/dt(max), consistent with our previous report in C57BL/6J mice. Surprisingly, we found that TNF-αTG mice exposed to IH showed a reduction in end-diastolic volume (38.7 ± 3.8 to 22.2 ± 2.1 ul; P < 0.01) and an increase in ejection fraction (29.4 ± 2.5 to 41.9 ± 3.1%; P < 0.05). In contrast to our previous study in C56Bl/6J mice, neither FVB nor TNF-αTG mice exhibited an upregulation in β-adrenergic expression or cAMP in response to IH exposure. We conclude that 4 wk of exposure to IH in mice induces adaptive responses that improve cardiac function in not only healthy animals but also in animals with underlying heart failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773770      PMCID: PMC3472476          DOI: 10.1152/japplphysiol.00185.2012

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors:  L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

3.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats.

Authors:  Z Tahawi; N Orolinova; I G Joshua; M Bader; E C Fletcher
Journal:  J Appl Physiol (1985)       Date:  2001-05

5.  Therapeutic effect of intermittent hypobaric hypoxia on myocardial infarction in rats.

Authors:  Wei-Qing Xu; Zhuo Yu; Yan Xie; Guo-Qian Huang; Xian-Hong Shu; Yi Zhu; Zhao-Nian Zhou; Huang-Tian Yang
Journal:  Basic Res Cardiol       Date:  2011-02-07       Impact factor: 17.165

Review 6.  Effect of episodic hypoxia on sympathetic activity and blood pressure.

Authors:  E C Fletcher
Journal:  Respir Physiol       Date:  2000-02

7.  Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.

Authors:  Yoshihiro Higuchi; Charles F McTiernan; Carole B Frye; Brian S McGowan; Tung O Chan; Arthur M Feldman
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

8.  Intermittent hypoxia increases insulin resistance in genetically obese mice.

Authors:  Vsevolod Y Polotsky; Jianguo Li; Naresh M Punjabi; Arnon E Rubin; Philip L Smith; Alan R Schwartz; Christopher P O'Donnell
Journal:  J Physiol       Date:  2003-07-23       Impact factor: 5.182

9.  Pulmonary hypertension and right ventricular hypertrophy caused by intermittent hypoxia and hypercapnia in the rat.

Authors:  E E Nattie; D Bartlett; K Johnson
Journal:  Am Rev Respir Dis       Date:  1978-10

10.  Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy.

Authors:  Vinciane Gaussin; James E Tomlinson; Christophe Depre; Stefan Engelhardt; Christopher L Antos; Gen Takagi; Lutz Hein; James N Topper; Stephen B Liggett; Eric N Olson; Martin J Lohse; Stephen F Vatner; Dorothy E Vatner
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

View more
  13 in total

Review 1.  The polymorphic and contradictory aspects of intermittent hypoxia.

Authors:  Isaac Almendros; Yang Wang; David Gozal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-16       Impact factor: 5.464

Review 2.  Humans In Hypoxia: A Conspiracy Of Maladaptation?!

Authors:  Jerome A Dempsey; Barbara J Morgan
Journal:  Physiology (Bethesda)       Date:  2015-07

Review 3.  Management of Sleep Disordered Breathing in Patients with Heart Failure.

Authors:  Connor P Oates; Manjula Ananthram; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 4.  Rodent models of sleep apnea.

Authors:  Eric M Davis; Christopher P O'Donnell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-27       Impact factor: 1.931

5.  Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart.

Authors:  Bruna Visniauskas; Juliana C Perry; Guiomar N Gomes; Amanda Nogueira-Pedro; Edgar J Paredes-Gamero; Sergio Tufik; Jair R Chagas
Journal:  Physiol Rep       Date:  2021-05

6.  Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling.

Authors:  Xueling Guo; Jin Shang; Yan Deng; Xiao Yuan; Die Zhu; Huiguo Liu
Journal:  Int J Mol Med       Date:  2015-04-24       Impact factor: 4.101

7.  Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia.

Authors:  Giuseppina Milano; Provvidenza Maria Abruzzo; Alessandra Bolotta; Marina Marini; Laura Terraneo; Barbara Ravara; Luisa Gorza; Maurizio Vitadello; Sabrina Burattini; Davide Curzi; Elisabetta Falcieri; Ludwig K von Segesser; Michele Samaja
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 8.  Hypoxic Conditioning as a New Therapeutic Modality.

Authors:  Samuel Verges; Samarmar Chacaroun; Diane Godin-Ribuot; Sébastien Baillieul
Journal:  Front Pediatr       Date:  2015-06-22       Impact factor: 3.418

9.  The impact of obesity and hypoxia on left ventricular function and glycolytic metabolism.

Authors:  Rosa H Rodriguez; Janelle L Bickta; Patrick Murawski; Christopher P O'Donnell
Journal:  Physiol Rep       Date:  2014-04-22

10.  Upregulated ATF6 contributes to chronic intermittent hypoxia-afforded protection against myocardial ischemia/reperfusion injury.

Authors:  Weikun Jia; Zhao Jian; Jingwei Li; Lin Luo; Liang Zhao; Yang Zhou; Fuqin Tang; Yingbin Xiao
Journal:  Int J Mol Med       Date:  2016-03-22       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.